02
025620.KO Jayjun Co Ltd
- Market cap
- KRW 90.4B
- P/E
- 11.1x
- P/B
- 1.12x
- ROE
- 14.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 025620.KO undervalued?
Graham number025620.KO trades 25.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Jayjun Co Ltd fundamental analysis
No fundamental analysis for Jayjun Co Ltd yet.
Jayjun Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Jayjun Co Ltd
Cha AI Healthcare Co., Ltd., together with its subsidiaries, manufactures and distributes cosmetic products in South Korea. The company offers facial care products, including masks/packs, skin/toner/mist, pads/patches, ampoules/serums/essence, lotion/emulsion, creams/gels, cleansing/peeling, sun care, and beauty accessories products; skin cells/texture, moisture/moisturizing, whitening/brightening, and sensitive/calm care products; nutritional/elasticity/anti-aging care prod…
Full company profileJayjun Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Jayjun Co Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 83.4B | 130B | 132B | 52.6B | 30.5B | 20.5B | 6.25B | 16.1B | 15.7B | 7.31B | 9.69B |
| Gross Profit | 27.5B | 67.3B | 63.7B | 7.83B | 5.94B | 2.53B | 905M | 7.97B | 7.35B | 2.06B | 2.54B |
| Operating Income | 13.3B | 22.3B | 7.14B | -52.0B | -11.3B | -17.3B | -7.98B | -9.07B | -4.85B | -7.10B | -5.11B |
| EBITDA | - | 24.5B | 3.66B | -76.2B | -14.0B | -35.1B | -18.1B | -5.29B | -7.59B | 3.21B | 16.9B |
| Net Income | 12.5B | 27.4B | -1.24B | -84.4B | -21.8B | -38.6B | -21.4B | -6.80B | -9.49B | 1.37B | 11.5B |
| EPS | - | 1,047 | -47 | -2,974 | -590 | -518 | -5,592 | -1,519 | -2,122 | 75 | 633 |
| Balance Sheet | |||||||||||
| Total Assets | 115B | 153B | 215B | 124B | 87.9B | 79.9B | 48.4B | 48.4B | 38.9B | 110B | 122B |
| Total Liabilities | 28.9B | 25.8B | 88.3B | 70.6B | 28.1B | 19.7B | 6.81B | 8.37B | 9.28B | 34.8B | 40.7B |
| Shareholders' Equity | 86.4B | 127B | 126B | 54.1B | 61.0B | 59.8B | 41.6B | 40.0B | 29.7B | 75.4B | 81.0B |
| Cash & Short-term Investments | 3.21B | 4.52B | 8.35B | 1.53B | 1.54B | 8.30B | 10.5B | 4.74B | 2.07B | 39.6B | 10.9B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 7.08B | -20.6B | -31.6B | 3.50B | -5.02B | -3.49B | -4.98B | -9.86B | -6.91B | -6.71B | -6.49B |
| Capital Expenditure | 12.9B | 39.7B | 8.78B | 693M | 428M | 242M | 919M | 396M | 244M | 600M | 239M |
| Free Cash Flow | - | -61.0B | -40.5B | 2.78B | -5.45B | -9.59B | -13.0B | -10.3B | -7.16B | -7.31B | -6.73B |
| Ratios | |||||||||||
| ROE | 14.5% | 21.6% | -1.0% | -156.0% | -35.7% | -64.5% | -51.5% | -17.0% | -32.0% | 1.8% | 14.2% |
| ROA | 10.9% | 17.9% | -0.6% | -68.1% | -24.8% | -48.3% | -44.3% | -14.1% | -24.4% | 1.2% | 9.5% |
| Net Profit Margin | 15.0% | 21.1% | -0.9% | -160.4% | -71.3% | -187.8% | -343.2% | -42.2% | -60.6% | 18.7% | 118.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Jayjun Co Ltd dividends
Jayjun Co Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 0.05:1 on Dec 19, 2022.
Who owns Jayjun Co Ltd
- Insiders 77.88%
- Institutions 0.01%
- Public & others 22.12%
- Shares outstanding 18.2M
- Free float 3.66M
Jayjun Co Ltd company profile
- Company name
- Jayjun Co Ltd
- Ticker
- 025620.KO
- ISIN
- KR7025620006
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 41
- Fiscal year end
- December
- Address
- 52 Seobinggo-ro 51-gil, Seoul, South Korea, 04384
- Phone
- 82 80 881 2001
- Website
- jayjun.co.kr
About Jayjun Co Ltd
Cha AI Healthcare Co., Ltd., together with its subsidiaries, manufactures and distributes cosmetic products in South Korea. The company offers facial care products, including masks/packs, skin/toner/mist, pads/patches, ampoules/serums/essence, lotion/emulsion, creams/gels, cleansing/peeling, sun care, and beauty accessories products; skin cells/texture, moisture/moisturizing, whitening/brightening, and sensitive/calm care products; nutritional/elasticity/anti-aging care products; and UV protection care products. The company was formerly known as Jayjun Cosmetic Co., Ltd. and changed its name to Cha AI Healthcare Co., Ltd. in December 2025. Cha AI Healthcare Co., Ltd. was founded in 1972 and is headquartered in Seoul, South Korea.
Jayjun Co Ltd management
1- Mr. Jung-Yoon LeeChief Executive Officer · born 1953